A Phase II Study of Estramustine, Docetaxel, and Exisulind in Patients with Hormone- Refractory Prostate Cancer: Results of Cancer and Leukemia Group B Trial 90004
Titel:
A Phase II Study of Estramustine, Docetaxel, and Exisulind in Patients with Hormone- Refractory Prostate Cancer: Results of Cancer and Leukemia Group B Trial 90004
Auteur:
Dawson, Nancy A. Halabi, Susan Ou, San-San Biggs, David D. Kessinger, Anne Vogelzang, Nicholas Clamon, Gerald H. Nanus, David M. Kelly, W. Kevin Small, Eric J.